Rubella Vaccine(Serum-free MRC-5 cells),Live (Tianjin Jinst Vaccine)

风疹减毒活疫苗(无血清MRC-5细胞)(天津津斯特疫苗)

Report date: 2022/11/09 20:01:39

Base Information

Drug NameRubella Vaccine(Serum-free MRC-5 cells),Live (Tianjin Jinst Vaccine)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRubellaRubulavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesTianjin Genstar Biotech Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsRubella
Inactive IndicationsRubulavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A